glutathione adduct PDF) Endogenous Adducts Phase III | Metabolism of

Higher capacity than standard formats Supports repeat and extended studies Efficient for ongoing research workflows Quality and formulation Each vial is lyophilized to maintain stability and support long-term storage under proper laboratory conditions

A systematic review analyzing multiple clinical trials confirmed that oral glutathione at doses of 250-500mg showed a significant reduction in melanin index compared to placebo over 8-12 weeks

It is a potent antioxidant and has been shown to support the body's immune system.*

Peptide Therapy may not be suitable for individuals with certain medical conditions, including: Pregnant or breastfeeding women Severe allergies to peptides Uncontrolled diabetes or certain hormone imbalances Its important to consult with your healthcare provider to determine if Peptide Therapy is right for you based on your health history